Marylin Mermod Schule

Jun 22, 2015

Marylin Mermod Schule has joined Sophia Genetics as CFO. She was previously the deputy director at Benjamin de Rothschild Bank, and before that, was the CEO and CFO of Swiss clinic La Metairie. 

More Like This

Apr 24, 2018

Kim Kelderman

Bio-Techne has hired Kim Kelderman as president of Diagnostics and Genomics, effective April 30. Based in California, Kelderman will lead Bio-Techne's diagnostics business, and drive and develop the company's initiatives in genomics and genomics-based diagnostics. He joins Bio-Techne from Thermo Fisher Scientific, where for the past three years he managed the platforms and content of the Genetic Sciences Division. In that position he was responsible for the instrumentation, software, consumables, and assays businesses, and brands including Applied Biosystems and legacy Affymetrix. Prior to being at Thermo Fisher, he was a segment leader at Becton Dickinson. 

Apr 24, 2018

Heiner Dreismann

Heiner Dreismann, former CEO of Roche Molecular Systems, has joined the executive advisory board of MyDx, maker of a multi-use handheld chemical analyzer designed for cannabis professionals and retail consumers. Under Dreismann’s leadership, Roche expanded its portfolio of molecular tests and instruments. Prior to his appointment as CEO of Roche Molecular, Dreismann held other senior positions within Roche, including head of global business development for Roche Diagnostics, business unit Europe manager for PCR, head of its business unit for microbiology, R&D positions in microbiology and infectious diseases, and head of manufacturing for infectious disease diagnostics.

Apr 24, 2018

Kenneth Berlin

Former Rosetta Genomics CEO Kenneth Berlin has been appointed president and CEO of Advaxis, effective April 23. Berlin had been president and CEO of Rosetta since 2009 before he stepped down on April 18. That firm and Genoptix have been trying to reach a deal for Genoptix's purchase of the company. Berlin previously has held executive positions at Johnson & Johnson, and J&J firms Veridex and Ortho-Clinical Diagnostics. 

Apr 23, 2018

Brad Kreger

Brad Kreger has become senior vice president of global operations at Fluidigm. Prior to joining the company, he was senior director of manufacturing operations in Thermo Fisher Scientific's clinical next-generation sequencing division. Before that, he was with Affymetrix for two decades, most recently as vice president of reagent manufacturing and global process engineering. Kreger holds an MBA from Western Governors University and a BS in biotechnology from Charter Oak State College.

Apr 20, 2018

Margo Georgiadis

Ancestry announced today that it has appointed Margo Georgiadis as CEO and member of its board of directors. Georgiadis will join the company on May 10. She will succeed Howard Hochhauser, who served as interim CEO since Oct 2017. Hochhauser will return to his position as Ancestry's CFO and COO. Georgiadis previously served as CEO at Mattel, and prior to that as President, Americas at Google.

Apr 20, 2018

William Bonello

NeoGenomics has appointed William Bonello VP of strategy, corporate development and investor relations. Bonello has served as the company's VP, treasurer, and director of corporate development since April of last year. Previously Bonello worked as a healthcare equity analyst covering diagnostic services and product stocks for Craig-Hallum, and as an equity analyst for Piper Jaffray, Wachovia Securities, and RBC Capital Markets. Bonello was also previously senior VP for investor relations at Laboratory Corporation of America.

Apr 17, 2018

Patrick Kaltenbach

Agilent said that Patrick Kaltenbach, senior VP for the company and president of Agilent's Life Sciences and Analytical Group, will leave the company on April 20. The company did not provide a reason for Kaltenbach's departure. The search for a replacement for his position is underway, Agilent said.

Apr 16, 2018

John Lubniewski

John Lubniewski has been promoted by HTG Molecular Diagnostics to president and chief operating officer. Lubniewski has been the company's chief business officer for the past seven years. He joined HTG from Ventana, now part of Roche, where he held several senior leadership roles, and was responsible for marketing and global accountability for all assay products. Prior to joining Ventana, he was with Corning.

Apr 16, 2018

Richard Williams

Richard Williams has become managing director and head of oncology programs at WuXi Nextcode. He joins the company from Grail, where he was lead medical director of the Circulating Cell-Free Genome Atlas program. Prior to that, he held positions in oncology drug development at Amgen and at Puma Technology. Williams holds B.Med.Sc and PhD degrees, as well as bachelor of medicine and bachelor of surgery degrees, from the University of Queensland in Australia.

Apr 13, 2018

Aleksandar Rajkovic

Aleksandar Rajkovic has become the first chief genomics officer of the University of California, San Francisco. He joins UCSF from the University of Pittsburgh Medical Center, where he was division director of reproductive genetics. In his new role, Rajkovic will direct the activities of UCSF's existing clinical genomics laboratories, in addition to leading efforts to apply genetics and genomics to clinical care within the health system.

Apr 13, 2018

Irwin Jacobs, Martin Wygod

Biological Dynamics has added Irwin Jacobs and Martin Wygod to its board of directors. Jacobs is a cofounder of semiconductor and telecommunications equipment firm Qualcomm, as well as chairman emeritus of the Salk Institute for Biological Studies. Wygod is director of Medco Containment Services and former chairman of WebMD Health. 

Apr 13, 2018

Debra Goff, Donna Mildvan, Melissa Miller, Frederick Nolte, Robin Patel

Curetis has established a US scientific advisory board consisting of five infectious disease experts. Debra Goff, Donna Mildvan, Melissa Miller, Frederick Nolte, and Robin Patel will support the clinical adoption of the firm's Unyvero System and lower respiratory tract infection assay recently cleared by the US Food and Drug Administration. 

Goff is currently an infectious diseases specialist with the One Health Antibiotic Stewardship team at The Ohio State University; Mildvan is professor of medicine at Icahn School of Medicine at Mount Sinai in New York; Miller is director of the clinical molecular microbiology laboratory at the University of North Carolina at Chapel Hill School of Medicine; Nolte is medical director of clinical labs and molecular pathology at the Medical University of South Carolina; and Patel is co-director of the clinical bacteriology laboratory, director of the infectious diseases research lab, and chair of the division of clinical microbiology at Mayo Clinic.

Apr 13, 2018

Heidi Rehm

Heidi Rehm last month became chief genomics officer in the Department of Medicine at Massachusetts General Hospital, where she is part of the Center for Genomic Medicine. In her new role, she will focus on the clinical implementation of genomics. Rehm remains medical director of the Broad Institute’s clinical research sequencing platform and an associate professor of pathology at MGH, Brigham and Women’s Hospital, and Harvard Medical School. She is also a leader and principal investigator of ClinGen, and a co-leader of the Broad Center for Mendelian Genomics. Previously, Rehm was the director of the Laboratory for Molecular Medicine at Partners Healthcare Personalized Medicine.

Apr 13, 2018

Michael Murray

Michael Murray has become director for clinical operations in the Center for Genomic Health at Yale University School of Medicine. He joins Yale from the Geisinger Health System, where he was director of clinical genomics and was leading the GenomeFIRST return of results program, which is part of Geisinger’s MyCode Community Heath Initiative. In his new role at Yale, he will similarly focus on bringing clinical genomics to large patient cohorts.

Apr 12, 2018

Richard Kivel

BC Platforms announced today that it has appointed Richard Kivel as company chairman. Kivel is currently managing director at Graybella Captial and holds various director positions in the US and Europe.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.